Topaz has over 20 years experience working with early-stage companies across a number of industries, including starting and selling three companies herself. Having worked in hi-tech, biotech, and even the wine industry, her key recent focus has been in the biotech arena, guiding companies through investment, development, FDA, manufacturing, product launch and exit, in the US and Australian markets.

From earlier years in the bio-medical space at the Garvan Institute, through to her recent Deputy Director role at the Mater Medical Research Institute, Topaz has worked on multiple sides of research, development, and commercialisation including CEO of Cytopeia, USA, and being an angel investor herself.  Strategy, funding and partnerships are her strengths and her company, Biothoughts, is dedicated to these services.

Topaz is a Graduate of the Australian Institute of Company Directors and currently sits on the Boards of: Australian Women Chamber of Commerce and Industry, Australian Employee Buyout Centre, and Women in Technology.